Download PDF
Horm Metab Res 2017; 49(02): 115-121
DOI: 10.1055/s-0042-118705
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Effects of Quercetin on Adiponectin-Mediated Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Double-Blind Clinical Trial

N. Rezvan
1   Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, International Campus Tehran University of Medical Sciences, Tehran, Iran
2   Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
,
A. Moini
3   Obstetrics and Gynecology Department, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4   Department of Obstetrics and Gynecology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran
,
L. Janani
5   Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
,
K. Mohammad
6   Department of Epidemiology and Biostatistics School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
,
A. Saedisomeolia
7   Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, International Campus, Tehran University of Medical Sciences, Tehran, Iran
8   Department of Pharmacy, School of Medicine, Western Sydney University, Sydney, NSW, Australia
,
M. Nourbakhsh
9   Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
,
S. Gorgani-Firuzjaee
10   Department of Medical Laboratory Sciences, School of Allied Health Medicine, AJA University of Medical Sciences, Tehran, Iran
,
M. Mazaherioun
7   Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, International Campus, Tehran University of Medical Sciences, Tehran, Iran
,
M. J. Hosseinzadeh-Attar
1   Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, International Campus Tehran University of Medical Sciences, Tehran, Iran
2   Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
› Author Affiliations
Further Information

Publication History

received 14 July 2016

accepted 28 September 2016

Publication Date:
07 November 2016 (online)

Also available at
   Permissions and Reprints

Abstract

Polycystic ovary syndrome (PCOS) is a heterogeneous, multi-causal, and genetically complex disorder, which is related to the failure in endocrine glands. Adiponectin has been reported to be low in PCOS, even in the absence of adiposity. Quercetin reduces serum glucose, insulin, triglycerides, and cholesterol levels and increases the expression and secretion of adiponectin. The aim of this study was to determine the effect of quercetin on the adiponectin-mediated insulin sensitivity in PCOS patients. Eighty-four women with PCOS were selected and randomly assigned to 2 groups of treatment and control. The treatment group received 1 g quercetin (two 500 mg capsules) daily for 12 weeks, and the control group received placebo. In addition to anthropometric assessments, fasting serum levels of total adiponectin, high-molecular-weight (HMW) adiponectin, glucose, insulin, testosterone, LH, and SHBG were also measured at the baseline and at the end of the trial. Quercetin could slightly increase the level of adiponectin by 5.56% as compared to placebo (adjusted p-value=0.001) and HMW adiponectin by 3.9% as compared to placebo (adjusted p-value=0.017), while it reduced the level of testosterone (0.71 ng/dl in quercetin vs. 0.77 ng/dl in placebo; p<0.001) and LH (8.42 IU/l in quercetin vs. 8.68 IU/l in placebo; p=0.009). HOMA-IR levels were also significantly (p<0.001) lower in quercetin (1.84) group compared to placebo group (2.21). Oral quercetin supplementation was effective in improving the adiponectin-mediated insulin resistance and hormonal profile of women with PCOS.

Key words

polycystic ovary syndrome - adiponectin - insulin resistance - quercetin

Supporting Information

 

  • References

  • 1 Dewailly D, Hieronimus S, Mirakian P, Hugues JN. Polycystic ovary syndrome (PCOS). Ann Endocrinol 2010; 71: 8-13
    CrossrefPubMedGoogle Scholar
  • 2 Baptiste CG, Battista MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 2010; 122: 42-52
    CrossrefPubMedGoogle Scholar
  • 3 Escobar-Morreale H, Villuendas G, Botella-Carretero J, Alvarez-Blasco F, Sanchon R, Luque-Ramirez M, San Millan J. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 2006; 21: 2257-2265
    CrossrefPubMedGoogle Scholar
  • 4 Mamaghani F, Zarghami N, Maleki M, Pourhassan-Moghaddam M, Hosseinpanah F. Variation of adiponectin levels in normal and obese subjects: possible correlation with lipid profiles. Int J Endocrinol Metab 2009; 170-178
    PubMedGoogle Scholar
  • 5 Groth SW. Adiponectin and polycystic ovary syndrome. Biol Res Nurs 2010; 12: 62-72
    CrossrefPubMedGoogle Scholar
  • 6 Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537-1545
    CrossrefPubMedGoogle Scholar
  • 7 Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ, Lam KS. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005; 280: 18073-18080
    CrossrefPubMedGoogle Scholar
  • 8 Wickham Iii EP, Cheang KI, Clore JN, Baillargeon J-P, Nestler JE. Total and high–molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism 2011; 60: 366-372
    CrossrefPubMedGoogle Scholar
  • 9 Lakhanpal P, Rai DK. Quercetin: a versatile flavonoid. Int J Med Update 2007; 2: 22-37
    PubMedGoogle Scholar
  • 10 Overman A, Chuang C, McIntosh M. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media. Int J Obes 2011; 35: 1165-1172
    CrossrefPubMedGoogle Scholar
  • 11 Yang L, Li XF, Gao L, Zhang YO, Cai GP. Suppressive effects of quercetin-3-O-(6″-feruloyl)-b-d-galactopyranoside on adipogenesis in 3T3-L1 preadipocytes through down-regulation of PPARg and C/EBPa expression. Phytother Res 2012; 26: 438-444
    CrossrefPubMedGoogle Scholar
  • 12 Jung UJ, Lee M-K, Park YB, Kang MA, Choi M-S. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol 2006; 38: 1134-1145
    CrossrefPubMedGoogle Scholar
  • 13 Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation. PLoS One 2013; 8: e63784
    CrossrefPubMedGoogle Scholar
  • 14 Stewart LK, Wang Z, Ribnicky D, Soileau JL, Cefalu WT, Gettys TW. Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity. Diabetologia 2009; 52: 514-523
    CrossrefPubMedGoogle Scholar
  • 15 Min YD, Choi CH, Bark H, Son HY, Park HH, Lee S, Park JW, Park EK, Shin HI, Kim SH. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kB and p38 MAPK in HMC-1 human mast cell line. Inflam Res 2007; 56: 210-215
    CrossrefPubMedGoogle Scholar
  • 16 Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008; 138: 1615-1621
    PubMedGoogle Scholar
  • 17 [Anonymous] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47
    CrossrefPubMedGoogle Scholar
  • 18 Jin F, Nieman DC, Shanely RA, Knab AM, Austin MD, Sha W. The variable plasma quercetin response to 12-week quercetin supplementation in humans. Eur J Clin Nutr 2010; 64: 692-697
    CrossrefPubMedGoogle Scholar
  • 19 Knab AM, Shanely RA, Jin F, Austin MD, Sha W, Nieman DC. Quercetin with vitamin C and niacin does not affect body mass or composition. Appl Physiol Nutr Metab 2011; 36: 331-338
    CrossrefPubMedGoogle Scholar
  • 20 Song J, Kwon O, Chen S, Daruwala R, Eck P, Park JB, Levine M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose. J Biol Chem 2002; 277: 15252-15260
    CrossrefPubMedGoogle Scholar
  • 21 Mazloom Z, Abdollahzadeh SM, Dabbaghmanesh MH, Rezaianzadeh A. The Effect of Quercetin Supplementation on Oxidative Stress, Glycemic Control, Lipid Profile and Insulin Resistance in Type 2 Diabetes: A Randomized Clinical Trial. J Health Sci Surveil Syst 2014; 2: 8-14
    PubMedGoogle Scholar
  • 22 Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvishi L. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int J Prevent Med 2013; 4: 777-785
    PubMedGoogle Scholar
  • 23 Namvaran F, Azarpira N, Rahimi-Moghaddam P, Dabbaghmanesh MH. Polymorphism of peroxisome proliferator-activated receptor gamma (PPARgamma) Pro12Ala in the Iranian population: relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes. Eur J Pharmacol 2011; 671: 1-6
    CrossrefPubMedGoogle Scholar
  • 24 Lee KW, Kim YJ, Kim D-O, Lee HJ, Lee CY. Major Phenolics in Apple and Their Contribution to the Total Antioxidant Capacity. J Agric Food Chem 2003; 51: 6516-6520
    CrossrefPubMedGoogle Scholar
  • 25 Nickel T, Hanssen H, Sisic Z, Pfeiler S, Summo C, Schmauss D, Hoster E, Weis M. Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur J Nutr 2011; 50: 163-172
    CrossrefPubMedGoogle Scholar
  • 26 Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin Ameliorates Metabolic Syndrome and Improves the Inflammatory Status in Obese Zucker Rats. Obesity 2008; 16: 2081-2087
    CrossrefPubMedGoogle Scholar
  • 27 Kobori M, Masumoto S, Akimoto Y, Oike H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res 2011; 55: 530-540
    CrossrefPubMedGoogle Scholar
  • 28 Wein S, Behm N, Petersen RK, Kristiansen K, Wolffram S. Quercetin enhances adiponectin secretion by a PPAR-g independent mechanism. Eur J Pharm Sci 2010; 41: 16-22
    CrossrefPubMedGoogle Scholar
  • 29 Gorgani-Firuzjaee S, Ahmadi S, Meshkani R. Palmitate induces SHIP2 expression via the ceramide-mediated activation of NF-κB, and JNK in skeletal muscle cells. Biochem Biophys Res Commun 2014; 450: 494-499
    CrossrefPubMedGoogle Scholar
  • 30 Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294: 23
    PubMedGoogle Scholar
  • 31 Pfeuffer M, Auinger A, Bley U, Kraus-Stojanowic I, Laue C, Winkler P, Rüfer CE, Frank J, Bösch-Saadatmandi C, Rimbach G, Schrezenmeir J. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr Metab Cardiovasc Dis 2013; 23: 403-409
    CrossrefPubMedGoogle Scholar
  • 32 Su H, Lau WB, Ma X-L. Hypoadiponectinemia in type 2 diabetes: molecular mechanisms and clinical significance. Clin Exp Pharmacol Physiol 2011; 38: 897-904
    CrossrefPubMedGoogle Scholar
  • 33 Tao T, Xu B, Liu W. Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome. Reprod Biol Endocrinol 2013; 11: 1477-7827
    PubMedGoogle Scholar
  • 34 Gorgani-Firuzjaee S, Khatami S, Meshkani R. SH2 domain-containing inositol 5-phosphatase (SHIP2) regulates de-novo lipogenesis and secretion of apoB100 containing lipoproteins in HepG2 cells. Biochem Biophys Res Commun 2015; 464: 1028-1033
    CrossrefPubMedGoogle Scholar
  • 35 Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 2009; 15: 297-307
    CrossrefPubMedGoogle Scholar
  • 36 Gorgani-Firuzjaee S, Adeli K, Meshkani R. Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells. Biochem Biophys Res Commun 2015; 464: 441-446
    CrossrefPubMedGoogle Scholar
  • 37 Lu M, Tang Q, Olefsky JM, Mellon PL, Webster NJG. Adiponectin Activates Adenosine Monophosphate-Activated Protein Kinase and Decreases Luteinizing Hormone Secretion in LβT2 Gonadotropes. Mol Endocrinol 2008; 22: 760-771
    CrossrefPubMedGoogle Scholar
  • 38 Mitchell M, Armstrong DT, Robker RL, Norman RJ. Adipokines: implications for female fertility and obesity. Reproduction 2005; 130: 583-597
    CrossrefPubMedGoogle Scholar
  • 39 Maggio M, Basaria S, Ceda G, Ble A, Ling S, Bandinelli S, Valenti G, Ferrucci L. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest 2005; 28: 116
    PubMedGoogle Scholar